Salix Coronary Anatomy

Organization
Artrya Ltd · Australia
Solution Type
Ready Product / Solution
Collaboration
Business Collaboration (Joint Venture), Licensing

1. Technology overview

Artrya Ltd (ACN 624 005 741) is an Australian company at 1257 Hay Street, West Perth, developing AI software for cardiac CT. Its privacy policy states that it is bound by the Australian Privacy Principles under the Privacy Act 1988.

Salix is web-based software that trained clinicians use to view and analyze cardiac CT data. It helps determine the presence and extent of coronary plaque and stenosis and quantifies calcium (calcium scoring) in patients who had coronary CT angiography. It works with CT images from any scanner and is positioned as an adjunct to clinician judgment. Salix Coronary Anatomy is on the Australian Register of Therapeutic Goods.

2. Highlighted features & specifications

  • Plaque analysis: determines presence and extent of coronary plaque.
  • Stenosis assessment: analyzes narrowing of coronary arteries on CCTA.
  • Calcium scoring: quantifies coronary calcium from cardiac CT.
  • Scanner-agnostic: accepts CT images from any scanner.
  • Web-based viewer: trained clinicians open and analyze studies in a browser.
  • Clinician-in-the-loop: positioned as an adjunct, not a replacement for clinician review.

3. Potential application

Cardiology departments in Vietnamese hospitals can use plaque and stenosis analysis to speed up CCTA reporting for chest pain patients. Health check centers can add calcium scoring to cardiovascular packages. Teleradiology groups can run the web tool across multi-site CT networks.

4. Benefits

Quantifies coronary plaque, stenosis and calcium from CCTA in one web tool. Works with CT images from any scanner, so no scanner replacement is needed. Has TGA listing (ARTG ID 347719) and a US FDA 510(k) clearance for the Salix Central USA product (K243038). Web delivery avoids local installation.

6. Other information

Registered as Artrya Ltd, ACN 624 005 741, West Perth, Australia. Company announcements list the ASX FDA clearance notice on 31 March 2025 and a capital raising in February 2025. Salix Central USA is cleared in the US (K243038). Founding year is not stated on the pages fetched.

Not ready to connect yet?

Save this solution and come back when you are ready to talk to the provider

Trusted by Our Partners

TechFest VietnamIOM – UN MigrationGIZ (Deutsche Gesellschaft für Internationale Zusammenarbeit)APED – Cục Phát triển doanh nghiệp tư nhân và kinh tế tập thểSIHUB – Startup and Innovation Hub of Ho Chi Minh CityHợp tác Đức (Deutsche Zusammenarbeit)SCE & Investment PromotionStartup Vietnam Foundation (SVF)National Startup Support Center (NSSC)01BoosterQuest VenturesBộ Tài chính (Ministry of Finance)ITPC – HCMC Investment and Trade Promotion CentreJICA – Japan International Cooperation AgencyNational Innovation Center (NIC)UK GovernmentBCG – Boston Consulting GroupHAWEEHeineken VietnamTalentnetMB BankVIREA – Liên chi hội Bất động sản Công nghiệp Việt NamJobTestGlobal Supply Chain Support Fund / Aavishkaar CapitalKDANPSE / JPS – Phúc Sang MinhG-AsiaPacificBlueScopeLPBankUlsan Center for Creative Economy & InnovationĐại học Bách khoa Hà Nội – Trường Điện - Điện tửVINK – Vietnam Innovation Network in KoreaTencent WeStart (Shenzhen)Ulsan CollegeK-StartupFaslinkShinhan Future's LabShinhan SecuritiesShinhan FinanceShinhan BankShinhan Life

Start with the right connection

We make innovation easy to access for every business everywhere. The next deal is you.

Contact Us